BioMarin Pharmaceutical Revenue

In the year 2024, BioMarin Pharmaceutical had annual revenue of $2.85B USD with 17.97% growth. BioMarin Pharmaceutical had revenue of $747.31M in the quarter ending December 31, 2024, with 15.65% growth.

Revenue

$2.85B

Revenue Growth

+17.97%

P/S Ratio

3.62

Revenue / Employee

$938.79K

Employees

3,040

Market Cap

9.98B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.85B	434.69M	17.97%
Dec 31, 2023	2.42B	323.19M	15.42%
Dec 31, 2022	2.10B	249.76M	13.53%
Dec 31, 2021	1.85B	-14.18M	-0.76%
Dec 31, 2020	1.86B	156.41M	9.18%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Intesa Sanpaolo	25.38B
UniCredit	23.99B
Enel SpA	78.95B
Ferrari	6.68B
Assicurazioni Generali	55.30B
Eni S.p.A.	91.17B
Leonardo S.p.a.	17.76B
Stellantis	156.88B

Revenue Rankings